The Impact and Cost-Effectiveness of a Four-Month Regimen for First-Line Treatment of Active Tuberculosis in South Africa.
BACKGROUND:A 4-month first-line treatment regimen for tuberculosis disease (TB) is expected to have a direct impact on patient outcomes and societal costs, as well as an indirect impact on Mycobacterium tuberculosis transmission. We aimed to estimate this combined impact in a high TB-burden country:...
Main Authors: | Gwenan M Knight, Gabriela B Gomez, Peter J Dodd, David Dowdy, Alice Zwerling, William A Wells, Frank Cobelens, Anna Vassall, Richard G White |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4696677?pdf=render |
Similar Items
-
Population-level impact of shorter-course regimens for tuberculosis: a model-based analysis.
by: Mariam O Fofana, et al.
Published: (2014-01-01) -
Modeling of novel diagnostic strategies for active tuberculosis - a systematic review: current practices and recommendations.
by: Alice Zwerling, et al.
Published: (2014-01-01) -
Cost-effectiveness of short, oral treatment regimens for rifampicin resistant tuberculosis
by: Sedona Sweeney, et al.
Published: (2022-01-01) -
Cost-effectiveness of short, oral treatment regimens for rifampicin resistant tuberculosis.
by: Sedona Sweeney, et al.
Published: (2022-01-01) -
Measuring Stigma to Assess the Social Justice Implications of Health-Related Policy Decisions: Application to Novel Treatment Regimens for Multidrug-Resistant Tuberculosis
by: David W. Dowdy, et al.
Published: (2020-04-01)